Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Cancer Lett. 2012 Oct 1;323(1):41-47. doi: 10.1016/j.canlet.2012.03.029. Epub 2012 Mar 30.
The phosphatase of regenerating liver-3 (PRL-3) gene is associated with metastasis in gastric cancer, and is believed to play a causative role by promoting tumor cell motility, invasion, and metastasis, but little is known of the mechanisms involved. We previously reported that PRL-3 expression is significantly higher in the tissues of primary gastric carcinomas with peritoneal metastasis. In the present study, we found that two microRNAs (miRNAs), miR-495 and miR-551a, predicted to target PRL-3, are downregulated in gastric carcinoma samples. The validation of this interaction between those two miRNAs and PRL-3 was confirmed by western blotting and quantitative real-time PCR (qPCR) in GC cell lines transfected with miR-495 and miR-551a mimics. Furthermore, the migration and invasion of GC cells were significantly inhibited by transfection with miR-495 or -551a mimics, and the mRNA and protein levels of PRL-3 were reduced in cells overexpressing miR-495 or -551a. Collectively, our findings suggest that miR-495 and miR-551a both act as tumor suppressors by targeting the PRL-3 oncogene and inhibiting gastric cancer cell migration and invasion. The findings of this study contribute to current understanding of the functions of miRNA mimics in GC gene therapy.
肝再生磷酸酶-3(PRL-3)基因与胃癌转移有关,被认为通过促进肿瘤细胞的迁移、侵袭和转移而起作用,但涉及的机制知之甚少。我们之前的报告表明,具有腹膜转移的原发性胃癌组织中 PRL-3 的表达明显更高。在本研究中,我们发现两个微 RNA(miRNA),miR-495 和 miR-551a,被预测靶向 PRL-3,在胃癌样本中下调。通过在转染 miR-495 和 miR-551a 模拟物的 GC 细胞系中进行 Western blot 和定量实时 PCR(qPCR)验证了这两种 miRNA 与 PRL-3 之间的相互作用。此外,转染 miR-495 或 miR-551a 模拟物可显著抑制 GC 细胞的迁移和侵袭,并且过表达 miR-495 或 miR-551a 的细胞中 PRL-3 的 mRNA 和蛋白水平降低。总之,我们的研究结果表明,miR-495 和 miR-551a 均可通过靶向 PRL-3 癌基因抑制胃癌细胞迁移和侵袭,发挥肿瘤抑制作用。本研究的结果有助于当前对 miRNA 模拟物在 GC 基因治疗中的功能的理解。